Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 26:11:633556.
doi: 10.3389/fonc.2021.633556. eCollection 2021.

A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique

Affiliations

A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique

Feng Teng et al. Front Oncol. .

Abstract

Objective: This study aimed to develop a least absolute shrinkage and selection operator (LASSO)-based multivariable normal tissue complication probability (NTCP) model to predict radiation-induced xerostomia in patients with nasopharyngeal carcinoma (NPC) treated with comprehensive salivary gland-sparing helical tomotherapy technique.

Methods and materials: LASSO with the extended bootstrapping technique was used to build multivariable NTCP models to predict factors of patient-reported xerostomia relieved by 50% and 80% compared with the level at the end of radiation therapy within 1 year and 2 years, R50-1year and R80-2years, in 203 patients with NPC. The model assessment was based on 10-fold cross-validation and the area under the receiver operating characteristic curve (AUC).

Results: The prediction model by LASSO with 10-fold cross-validation showed that radiation-induced xerostomia recovery could be predicted by prognostic factors of R50-1year (age, gender, T stage, UICC/AJCC stage, parotid Dmean, oral cavity Dmean, and treatment options) and R80-2years (age, gender, T stage, UICC/AJCC stage, oral cavity Dmean, N stage, and treatment options). These prediction models also demonstrated a good performance by the AUC.

Conclusion: The prediction models of R50-1year and R80-2years by LASSO with 10-fold cross-validation were recommended to validate the NTCP model before comprehensive salivary gland-sparing radiation therapy in patients with NPC.

Keywords: LASSO; helical tomotherapy technique; nasopharyngeal carcinoma; prediction model; xerostomia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Delineation of target volume Red line: pGTVnx; brown line: pGTVnd; pink line: PTV1; dark green line: oral cavity; blue line: parotid gland; green line: submandibular gland.
Figure 2
Figure 2
Comparison of the mean dose (Dmean) of PG, SMG, and OC with different T (A) and N (B) stages.
Figure 3
Figure 3
LASSO coefficient profiles of the eleven R50-1year (A) and sixteen R80-2years (B) related events with non-zero coefficients determined by the optimal lambda.

Similar articles

Cited by

References

    1. Sun XS, Li XY, Chen QY, Tang TQ, Mai HQ. Future of Radiotherapy in Nasopharyngeal Carcinoma. Br J Radiol (2019) 92:1102:20190209. 10.1259/bjr.20190209 - DOI - PMC - PubMed
    1. Tribius S, Sommer J, Prosch C, Bajrovic A, Muenscher A, Blessmann M, et al. . Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland? Strahlenther Onkol (2013) 189:216–22. 10.1007/s00066-012-0257-2 - DOI - PubMed
    1. Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys (1994) 28:847–56. 10.1016/0360-3016(94)90104-x - DOI - PubMed
    1. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A, et al. . Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys (2003) 57:61–70. 10.1016/s0360-3016(03)00361-4 - DOI - PubMed
    1. Lee TF, Liou MH, Ting HM, Chang LY, Lee HY, Leung SW, et al. . Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy. Sci Rep (2015) 5:13165. 10.1038/srep13165 - DOI - PMC - PubMed

LinkOut - more resources